Skip to main navigation
Prelude Therapeutics
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • CDK9
    • MCL1
    • CDK4/6
    • SMARCA2
    • Discovery Engine
    • Publications
  • Clinical Trials
    • Overview
    • PRT2527 Trials
    • PRT1419 Trials
    • PRT3645 Trials
    • PRT3789 Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact

Contact IR

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • CDK9
    • MCL1
    • CDK4/6
    • SMARCA2
    • Discovery Engine
    • Publications
  • Clinical Trials
    • Overview
    • PRT2527 Trials
    • PRT1419 Trials
    • PRT3645 Trials
    • PRT3789 Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact
Print Page
RSS Feeds
Email Alerts
Search
preludetx.com

© Prelude Therapeutics
200 Powder Mill Road
Wilmington, DE 19803
(302) 467-1280

  • About
  • Science
  • Clinical Trials
  • Investors
  • News
  • Life at Prelude
  • Contact
visit our Twitter page visit our LinkedIn page Terms of Use Privacy Policy
logo
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • CDK9
    • MCL1
    • CDK4/6
    • SMARCA2
    • Discovery Engine
    • Publications
  • Clinical Trials
    • Overview
    • PRT2527 Trials
    • PRT1419 Trials
    • PRT3645 Trials
    • PRT3789 Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact